Scientific Article
previous document  unige:106698  next document
add to browser collection
Title

SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease
Authors
Ramirez, Alfredo
van der Flier, Wiesje M
Herold, Christine
Ramonet, David
CollaborationWith : Popp, Julius
Published in Human Molecular Genetics. 2014, vol. 23, no. 24, p. 6644-6658
Abstract Cerebrospinal fluid amyloid-beta 1-42 (Aβ1-42) and phosphorylated Tau at position 181 (pTau181) are biomarkers of Alzheimer's disease (AD). We performed an analysis and meta-analysis of genome-wide association study data on Aβ1-42 and pTau181 in AD dementia patients followed by independent replication. An association was found between Aβ1-42 level and a single-nucleotide polymorphism in SUCLG2 (rs62256378) (P = 2.5×10(-12)). An interaction between APOE genotype and rs62256378 was detected (P = 9.5 × 10(-5)), with the strongest effect being observed in APOE-ε4 noncarriers. Clinically, rs62256378 was associated with rate of cognitive decline in AD dementia patients (P = 3.1 × 10(-3)). Functional microglia experiments showed that SUCLG2 was involved in clearance of Aβ1-42.
Keywords Aged — Alzheimer Disease/cerebrospinal fluid/genetics/pathology — Amyloid beta-Peptides/cerebrospinal fluid/genetics — Apolipoprotein E4/cerebrospinal fluid/genetics — Cognition — Female — Gene Expression Regulation — Genome-Wide Association Study — Humans — Male — Nuclear Proteins/cerebrospinal fluid/genetics — Peptide Fragments/cerebrospinal fluid/genetics — Phosphorylation — Polymorphism — Single Nucleotide — RNA-Binding Proteins/cerebrospinal fluid/genetics — Serine-Arginine Splicing Factors — Signal Transduction — tau Proteins/cerebrospinal fluid/genetics
Identifiers
PMID: 25027320
Full text
Article (Published version) (608 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Citation
(ISO format) 		RAMIREZ, Alfredo et al. SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease. In: Human Molecular Genetics, 2014, vol. 23, n° 24, p. 6644-6658. doi: 10.1093/hmg/ddu372 https://archive-ouverte.unige.ch/unige:106698

172 hits

1 download

Contact an author

Update request

Update

Deposited on : 2018-07-27

Export document
Format :
Citation style :